A multi-center effectiveness comparison study of fruquintinib with constructed external control cohort of other targeted kinase inhibitors using real-world data in third-line treatment of metastatic colorectal cancer

A multi-center effectiveness comparison study of fruquintinib with constructed external control cohort of other targeted kinase inhibitors using real-world data in third-line treatment of metastatic colorectal cancer

ObjectiveThe objective of this study was to assess the comparative efficacy in third-line setting for metastatic CRC (mCRC) patients using matched population of FRESCO trial with fruquintinib and real-world data with other TKIs.Materials and methodsThe arm of fruquintinib from the FRESCO phase III t...

Full description

Bibliographic Details
Main Authors: Ying Jin, Jin Li, Lin Shen, Jianming Xu, Yanqiao Zhang, Jingdong Zhang, Hongming Pan, Xiujuan Qu, Yamin Chen, Qiang Zhang, Jinnan Li, Miaomiao Sun, Shukui Qin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
fruquintinib
FRESCO
real-world data
metastatic colorectal cancer
tyrosine kinase inhibitors
progression free survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1044328/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1044328/full

Similar Items